These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vulnerability of allogeneic and xenogeneic pancreatic islets to alloantisera. Frangipane LG; Poole TW; Barker CF; Silvers WK Transplant Proc; 1977 Mar; 9(1):371-3. PubMed ID: 141129 [No Abstract] [Full Text] [Related]
3. The effect of immunosuppressive treatment on the survival of allogeneic islets of Langerhans in rats. Marquet RL; Heystek GA Transplantation; 1975 Nov; 20(5):428-31. PubMed ID: 128854 [No Abstract] [Full Text] [Related]
4. Isolated islet transplantation in experimental diabetes. Gray BN; Watkins E Aust J Exp Biol Med Sci; 1976 Feb; 54(1):57-70. PubMed ID: 133661 [TBL] [Abstract][Full Text] [Related]
5. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide. Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492 [TBL] [Abstract][Full Text] [Related]
6. Effects of a combined antigen-cyclosporine regimen in four transplantation models. Didlake R; Kakazaki K; Yoshimura N; Merrell R; Kahan BD Transplant Proc; 1987 Feb; 19(1 Pt 2):1281-3. PubMed ID: 3152626 [No Abstract] [Full Text] [Related]
7. Pancreatic islet isografts, allografts, and xenografts: comparison of morphology and function. Weber C; Zatrigi A; Weil R; McIntosh R; Hardy MA; Reemtsma K Surgery; 1976 Feb; 79(02):144-51. PubMed ID: 128838 [TBL] [Abstract][Full Text] [Related]
10. Transplantation of isolated pancreatic islets across strong and weak histocompatibility barriers. Reckard CR; Barker CF Transplant Proc; 1973 Mar; 5(1):761-3. PubMed ID: 4266674 [No Abstract] [Full Text] [Related]
11. Effect of intrahepatically implanted islets of Langerhans on hepatic function in the rat. Amamoo DG; Woods JE; Holley KE Mayo Clin Proc; 1975 Jul; 50(7):416-9. PubMed ID: 125372 [TBL] [Abstract][Full Text] [Related]
13. The TheraCyte™ device protects against islet allograft rejection in immunized hosts. Kumagai-Braesch M; Jacobson S; Mori H; Jia X; Takahashi T; Wernerson A; Flodström-Tullberg M; Tibell A Cell Transplant; 2013; 22(7):1137-46. PubMed ID: 23043940 [TBL] [Abstract][Full Text] [Related]
14. The importance of donor MHC compatibility in the allo- and autoimmune destruction of islet grafts in the BB rat. Stegall MD; Chabot JA; Tezuka K; Reemtsma K; Hardy MA Transplant Proc; 1990 Apr; 22(2):844. PubMed ID: 2109414 [No Abstract] [Full Text] [Related]
15. Tolerance induction to multiple donor rat islet allografts by intrathymic inoculation of spleen cell membrane antigens. Qian T; Ricordi C; Schachner R; Inverardi L; Alejandro R Transplant Proc; 1995 Dec; 27(6):3390. PubMed ID: 8540012 [No Abstract] [Full Text] [Related]
16. Transplantation of intact pancreatic islets in rats. Ballinger WF; Lacy PE Surgery; 1972 Aug; 72(2):175-86. PubMed ID: 4262169 [No Abstract] [Full Text] [Related]
17. Oral tolerance and allografts: can multiple oral administrations of low doses of highly purified islets induce peripheral tolerance in pancreatic islet allografts? Senesi B; Curiale V; Lione L; Puddu A; Pedemonte A; Pastorino A; Viviani GL Transplant Proc; 1998 Mar; 30(2):545-9. PubMed ID: 9532171 [No Abstract] [Full Text] [Related]
18. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides. Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717 [TBL] [Abstract][Full Text] [Related]
19. Immunological studies in diabetic rat recipients with a pancreatic islet cell allograft in the brain. Tze WJ; Tai J Transplantation; 1989 Jun; 47(6):1053-7. PubMed ID: 2499961 [TBL] [Abstract][Full Text] [Related]